Coagulation profiles in dogs with congenital portosystemic shunts before and after surgical attenuation

Journal of Veterinary Internal Medicine

Volumn 20, Issue 6, 2006, Pages 1319-1326

  Kummeling, Anne ^a   Teske, Erik ^a   Rothuizen, Jan ^a   Van Sluijs, Frederik J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Coagulation factors; Hemostasis; Hepatic disease; Procoagulant proteins

Indexed keywords

BLOOD CLOTTING FACTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CLOTTING TIME; CASE CONTROL STUDY; CONGENITAL MALFORMATION; DOG; DOG DISEASE; FEMALE; MALE; OVARIECTOMY; PARTIAL THROMBOPLASTIN TIME; PORTAL VEIN; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; PROTHROMBIN TIME; THROMBOCYTE COUNT;

ANIMALS; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FEMALE; MALE; OVARIECTOMY; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PORTAL SYSTEM; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; PROTHROMBIN TIME; WHOLE BLOOD COAGULATION TIME;

ANIMALIA; CANIS FAMILIARIS;

EID: 33845716388     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[1319:CPIDWC]2.0.CO;2     Document Type: Article

References (27)

1. van den Ingh TSGAM, Rothuizen J, Meyer HP. Circulatory disorders of the liver in dogs and cats. Vet Quart 1995;17:70-76.
2. Meyer HP, Rothuizen J, van Sluijs FJ, et al. Progressive remission of portosystemic shunting in 23 dogs after partial closure of congenital portosystemic shunts. Vet Rec 1999;144:133-137.
3. Hottinger HA, Walshaw R, Hauptman JG. Long-term results of complete and partial ligation of congenital portosystemic shunts in dogs. Vet Surg 1995;24:331-336.
4. Hunt GB, Hughes J. Outcomes after extrahepatic portosystemic shunt ligation in 49 dogs. Aust Vet J 1999;77:303-307.
5. Wolschrijn CF, Mahapokai W, Rothuizen J, et al. Gauged attenuation of congenital portosystemic shunts: Results in 160 dogs and 15 cats. Vet Quart 2000;22:94-98.
6. Kummeling A, van Sluijs FJ, Rothuizen J. Prognostic implications of the degree of shunt narrowing and of the portal vein diameter in dogs with congenital portosystemic shunts. Vet Surg 2004;33:17-24.
7. Papazoglou LG, Monnet E, Seim HB. Survival and prognostic indicators for dogs with intrahepatic portosystemic shunts: 32 cases (1990-2000). Vet Surg 2002;31:561-570.
8. Tobias KM. Portosystemic shunts and other hepatic vascular anomalies. In: Slatter D, ed. Textbook of Small Animal Surgery. Philadelphia, PA: WB Saunders; 2003:727-752.
9. Kerwin SC, Mauldin GE. Hemostasis, surgical bleeding and transfusion. In: Slatter D, ed. Textbook of Small Animal Surgery. Philadelphia, PA: WB Saunders; 2003:44-65.
10. Niles JD, Williams JM, Cripps PJ. Hemostatic profiles in 39 dogs with congenital portosystemic shunts. Vet Surg 2001;30:97-104.
11. Prater MR. Acquired coagulopathy II: liver disease. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:560-564.
12. Mammen EF. Coagulation defects in liver disease. Med Clin N Am 1994;78:545-554.
13. Lisciandro SC, Hohenhaus A, Brooks M. Coagulation abnormalities in 22 cats with naturally occurring liver disease. J Vet Intern Med 1998;12:71-75.
14. Badylak SF, Dodds WJ, Van Vleet JF. Plasma coagulation factor abnormalities in dogs with naturally occurring hepatic disease. Am J Vet Res 1983;44:2336-2340.
15. Rothuizen J, van den Ingh TS. Rectal ammonia tolerance test in the evaluation of portal circulation in dogs with liver disease. Res Vet Sci 1982;33:22-25.
16. Rothuizen J. Portosystemic hepatic encephalopathy related with congenital and acquired hepatopathies in the dog. Adv Vet Sci Comp Med 1993;37:403-416.
17. Mischke R. Optimization of coagulometric tests that incorporate human plasma for determination of coagulation factor activities in canine plasma. Am J Vet Res 2001;62:625-629.
18. Mischke R, Nolte IJA. Hemostasis: introduction, overview, laboratory techniques. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:519-525.
19. Bateman SW, Mathews KA, Abrams-Ogg ACG, et al. Evaluation of the effect of storage at -70°C for six months on hemostatic function testing in dogs. Can J Vet Res 1999;63:216-220.
20. Kemkes-Matthes B, Bleyl H, Matthes KJ. Coagulation activation in liver diseases. Thromb Res 1991;64:253-261.
21. Kerr R. New insights into haemostasis in liver failure. Blood Coagul Fibrinolysis 2003;14:S43-S45.
22. Mammen EF. Acquired coagulation protein defects. In: Bick RL, ed. Hematology, Clinical and Laboratory Practice. St Louis, MO: Mosby; 1993:1449-1462.
23. Burns ER, Goldberg SN, Wenz B. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time. Am J Clin Pathol 1993;100:94-98.
24. Littlewood JD. Disorders of secondary haemostasis. In: Day MJ, Mackin A, Littlewood JD, eds. BSAVA Manual of Canine and Feline Haematology and Transfusion Medicine. Gloucester: British Small Animal Veterinary Association, 2000:209-215.
25. Dodds WJ. Other hereditary coagulopathies. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:1030-1036.
26. Mammen EF. Coagulopathies of liver disease. Clin Lab Med 1994;14:769-780.
27. Rothuizen J, Desmet VJ, van den Ingh TSGAM, et al. Sampling and handling of liver tissue. In: Rothuizen J, et al. eds. WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease. Edinburgh: Churchill Livingstone; 2006:5-14.